Literature DB >> 19609046

Microvascular angina. The possible role of inflammation, uric acid, and endothelial dysfunction.

Sherif A Sakr1, Tarek M Abbas, Maged Z Amer, Eid M Dawood, Nader El-Shahat, Ibraheim A Abdel Aal, Mahmoud M Ramadan.   

Abstract

Microvascular angina is a condition characterized by angina-like chest pain and normal coronary angiography. Endothelial dysfunction and systemic inflammation with elevated serum high-sensitive C-reactive protein (hsCRP) levels play a role in its pathogenesis. This study aimed to explore the possible relation between CRP, brachial flow-mediated dilatation (FMD), and microvascular angina.We included 21 patients with attacks of chest pain diagnosed as microvascular angina (study group) and 10 normal asymptomatic subjects (control group). Patients and controls were thoroughly examined clinically and by echocardiography, electrocardiography, and brachial FMD (using external brachial ultrasonography). Serum hsCRP and uric acid levels were assessed in all subjects.A significantly higher mean hsCRP level was found in the study group compared to controls (11.5+/-3.8 versus 3.34+/-1.5 mg/L; P<0.001). FMD of the brachial artery showed significant impairment in patients with microvascular angina compared to controls (0.16+/-0.06 versus 0.76+/-0.09 mm; P<0.001). There were significantly higher total cholesterol (196.1+/-44.4 versus 159.8+/-14.5 mg/dL; P=0.018) and triglyceride levels (185.0+/-103.2 versus 113.0+/-17.6 mg/dL; P=0.038) in the patients compared to controls; but there was a statistically insignificant difference in mean serum uric acid levels between these two groups. There were no significant correlations between the brachial FMD and any of the clinical variables studied (apart from ankle/brachial index). Microvascular angina may have an inflammatory element (reflected as a higher serum hsCRP level), together with a contribution by endothelial dysfunction (reflected as impaired brachial artery FMD); while serum uric acid is possibly not associated with microvascular angina.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19609046     DOI: 10.1536/ihj.50.407

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  11 in total

Review 1.  Nonacute coronary syndrome anginal chest pain.

Authors:  Megha Agarwal; Puja K Mehta; C Noel Bairey Merz
Journal:  Med Clin North Am       Date:  2010-03       Impact factor: 5.456

Review 2.  Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade.

Authors:  C Noel Bairey Merz; Carl J Pepine; Mary Norine Walsh; Jerome L Fleg
Journal:  Circulation       Date:  2017-03-14       Impact factor: 29.690

3.  Determinants of vascular function in patients with chronic gout.

Authors:  Robert D Brook; Srilakshmi Yalavarthi; James D Myles; Shokoufeh Khalatbari; Rita Hench; Susan Lustig; Wendy Marder; Adam Neidert; Mariana J Kaplan
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-12-22       Impact factor: 3.738

4.  Uric Acid Is Associated With Inflammation, Coronary Microvascular Dysfunction, and Adverse Outcomes in Postmenopausal Women.

Authors:  Megha Prasad; Eric L Matteson; Joerg Herrmann; Rajiv Gulati; Charanjit S Rihal; Lilach O Lerman; Amir Lerman
Journal:  Hypertension       Date:  2016-12-19       Impact factor: 10.190

Review 5.  Allopurinol, uric acid, and oxidative stress in cardiorenal disease.

Authors:  Markus Riegersperger; Adrian Covic; David Goldsmith
Journal:  Int Urol Nephrol       Date:  2011-03-10       Impact factor: 2.370

Review 6.  Non-obstructive Plaque and Treatment of INOCA: More to Be Learned.

Authors:  Lina Ya'Qoub; Islam Y Elgendy; Carl J Pepine
Journal:  Curr Atheroscler Rep       Date:  2022-07-04       Impact factor: 5.967

7.  The association of brachial flow-mediated dilation and high-sensitivity C-reactive protein levels with Duke treadmill score in patients with suspected microvascular angina.

Authors:  Chufan Luo; Yi Li; Donghong Liu; Chengheng Hu; Zhimin Du
Journal:  Exp Clin Cardiol       Date:  2012

8.  A Brief History of Cardiac Syndrome X: A Biochemical View.

Authors:  Yousef Rasmi; Maryam Majidinia; Fariba Khosravifar; Fatemeh Kheradmand
Journal:  J Tehran Heart Cent       Date:  2017-01

9.  Standard exercise stress testing attenuates peripheral microvascular function in patients with suspected coronary microvascular dysfunction.

Authors:  Massimo Nardone; Steven Miner; Mary McCarthy; Heather Edgell
Journal:  BMC Sports Sci Med Rehabil       Date:  2021-02-27

Review 10.  Syndrome of Nonobstructive Coronary Artery Diseases: A Comprehensive Overview of Open Artery Ischemia.

Authors:  Lina Ya'qoub; Islam Y Elgendy; Carl J Pepine
Journal:  Am J Med       Date:  2021-07-31       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.